230 related articles for article (PubMed ID: 35980204)
1. Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus.
Chiem K; Park JG; Morales Vasquez D; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Oct; 10(5):e0237922. PubMed ID: 35980204
[TBL] [Abstract][Full Text] [Related]
2. Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2.
Morales Vasquez D; Chiem K; Silvas J; Park JG; Ye C; Martínez-Sobrido L
J Vis Exp; 2021 Nov; (177):. PubMed ID: 34806704
[TBL] [Abstract][Full Text] [Related]
3. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
Chiem K; Morales Vasquez D; Park JG; Platt RN; Anderson T; Walter MR; Kobie JJ; Ye C; Martinez-Sobrido L
J Virol; 2021 Mar; 95(7):. PubMed ID: 33431557
[TBL] [Abstract][Full Text] [Related]
4. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern
Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L
J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697
[TBL] [Abstract][Full Text] [Related]
5. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507
[TBL] [Abstract][Full Text] [Related]
6. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
7. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
Ye C; Chiem K; Park JG; Silvas JA; Morales Vasquez D; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; de la Torre JC; Martinez-Sobrido L
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34561300
[TBL] [Abstract][Full Text] [Related]
9. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
10. Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.
Morales Vasquez D; Chiem K; Ye C; Martinez-Sobrido L
Methods Mol Biol; 2022; 2524():235-248. PubMed ID: 35821476
[TBL] [Abstract][Full Text] [Related]
11. A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections.
Nogales A; Ávila-Pérez G; Rangel-Moreno J; Chiem K; DeDiego ML; Martínez-Sobrido L
J Virol; 2019 May; 93(10):. PubMed ID: 30867298
[TBL] [Abstract][Full Text] [Related]
12. Bi-Reporter Vaccinia Virus for Tracking Viral Infections
Chiem K; Lorenzo MM; Rangel-Moreno J; Garcia-Hernandez ML; Park JG; Nogales A; Blasco R; Martínez-Sobrido L
Microbiol Spectr; 2021 Dec; 9(3):e0160121. PubMed ID: 34817228
[TBL] [Abstract][Full Text] [Related]
13. Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for
Utrilla-Trigo S; Jiménez-Cabello L; Marín-López A; Illescas-Amo M; Andrés G; Calvo-Pinilla E; Lorenzo G; van Rijn PA; Ortego J; Nogales A
Microbiol Spectr; 2024 Mar; 12(3):e0249323. PubMed ID: 38353566
[TBL] [Abstract][Full Text] [Related]
14. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
15. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
Nguyen HT; Falzarano D; Gerdts V; Liu Q
J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
[TBL] [Abstract][Full Text] [Related]
18. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
19. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X; Muruato AE; Zhang X; Lokugamage KG; Fontes-Garfias CR; Zou J; Liu J; Ren P; Balakrishnan M; Cihlar T; Tseng CK; Makino S; Menachery VD; Bilello JP; Shi PY
Nat Commun; 2020 Oct; 11(1):5214. PubMed ID: 33060595
[TBL] [Abstract][Full Text] [Related]
20. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
